P.K. Tandon

470 total citations
10 papers, 335 citations indexed

About

P.K. Tandon is a scholar working on Economics and Econometrics, Physiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, P.K. Tandon has authored 10 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Economics and Econometrics, 4 papers in Physiology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in P.K. Tandon's work include Health Systems, Economic Evaluations, Quality of Life (5 papers), Genomics and Rare Diseases (2 papers) and Diet and metabolism studies (2 papers). P.K. Tandon is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (5 papers), Genomics and Rare Diseases (2 papers) and Diet and metabolism studies (2 papers). P.K. Tandon collaborates with scholars based in United States, Canada and Chile. P.K. Tandon's co-authors include Richard P. Schwarz, Michael P. McDermott, Curt R. Freed, Warren Olanow, Stanley Fahn, Ira Shoulson, Charles H. Adler, Christopher G. Goetz, Robert A. Hauser and Joanne Wuu and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Epidemiology and Journal of Bone and Mineral Research.

In The Last Decade

P.K. Tandon

8 papers receiving 329 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P.K. Tandon United States 7 123 78 57 48 44 10 335
Thomas S. Vates United States 14 47 0.4× 42 0.5× 15 0.3× 69 1.4× 138 3.1× 37 625
Meera Ramani Canada 10 335 2.7× 62 0.8× 14 0.2× 162 3.4× 94 2.1× 11 745
Melina G.H.E. den Brok Netherlands 8 193 1.6× 108 1.4× 17 0.3× 45 0.9× 59 1.3× 12 471
Lindsey Hughes United Kingdom 5 87 0.7× 31 0.4× 98 1.7× 20 0.4× 60 1.4× 7 600
Aiesha Ahmed United States 9 182 1.5× 19 0.2× 10 0.2× 44 0.9× 41 0.9× 28 349
Maria Julia Machline Carrion Brazil 4 28 0.2× 33 0.4× 33 0.6× 19 0.4× 35 0.8× 5 178
Carlos Zúñiga‐Ramírez Mexico 12 348 2.8× 22 0.3× 13 0.2× 119 2.5× 36 0.8× 41 537
Avni Shah United States 11 97 0.8× 26 0.3× 9 0.2× 70 1.5× 74 1.7× 14 661
Silvia Gallo Italy 8 182 1.5× 9 0.1× 18 0.3× 49 1.0× 77 1.8× 16 310
Manuel Seijo‐Martínez Spain 14 208 1.7× 16 0.2× 12 0.2× 54 1.1× 84 1.9× 22 453

Countries citing papers authored by P.K. Tandon

Since Specialization
Citations

This map shows the geographic impact of P.K. Tandon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P.K. Tandon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P.K. Tandon more than expected).

Fields of papers citing papers by P.K. Tandon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P.K. Tandon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P.K. Tandon. The network helps show where P.K. Tandon may publish in the future.

Co-authorship network of co-authors of P.K. Tandon

This figure shows the co-authorship network connecting the top 25 collaborators of P.K. Tandon. A scholar is included among the top collaborators of P.K. Tandon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P.K. Tandon. P.K. Tandon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Portale, Anthony A., Leanne M. Ward, Kathryn Dahir, et al.. (2024). Nephrocalcinosis and kidney function in children and adults with X-linked hypophosphatemia: baseline results from a large longitudinal study. Journal of Bone and Mineral Research. 39(10). 1493–1502. 4 indexed citations
2.
Tandon, P.K. & Emil Kakkis. (2021). The multi-domain responder index: a novel analysis tool to capture a broader assessment of clinical benefit in heterogeneous complex rare diseases. Orphanet Journal of Rare Diseases. 16(1). 183–183. 19 indexed citations
3.
Moscicki, Richard & P.K. Tandon. (2017). Drug-Development Challenges for Small Biopharmaceutical Companies. New England Journal of Medicine. 376(5). 469–474. 14 indexed citations
4.
Kakkis, Emil, Gerald F. Cox, Mark P. Hayes, et al.. (2015). Recommendations for the development of rare disease drugs using the accelerated approval pathway and for qualifying biomarkers as primary endpoints. Orphanet Journal of Rare Diseases. 10(1). 16–16. 36 indexed citations
5.
Goetz, Christopher G., Joanne Wuu, Michael P. McDermott, et al.. (2008). Placebo response in Parkinson's disease: Comparisons among 11 trials covering medical and surgical interventions. Movement Disorders. 23(5). 690–699. 181 indexed citations
6.
Tandon, P.K., Vincent G. Bain, Ross T. Tsuyuki, & Scott Klarenbach. (2007). Systematic review: renal and other clinically relevant outcomes in hepatorenal syndrome trials. Alimentary Pharmacology & Therapeutics. 25(9). 1017–1028. 8 indexed citations
7.
McMahon, Robert C., Frank E. Harrell, & P.K. Tandon. (1991). Analysis of nonfatal outcomes in clinical trials when mortality is present. Controlled Clinical Trials. 12(5). 625–625.
8.
Tandon, P.K.. (1990). Applications of global statistics in analysing quality of life data. Statistics in Medicine. 9(7). 819–827. 28 indexed citations
9.
10.
Tandon, P.K., et al.. (1989). Analysis of quality of life data from a randomized, placebo-controlled heart-failure trial. Journal of Clinical Epidemiology. 42(10). 955–962. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026